Precision BioSciences gets FDA fast track for DMD gene therapy

March 9, 2026 7:01 AM

Precision BioSciences Inc. (NASDAQ: DTIL) announced the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD for treating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found